Showing results (501-510 of 525) with videos related to

Sort By:
Pageof 53
European Journal of Pharmacology|August 29, 2017
Tobacco's minor alkaloids: Effects on place conditioning and nucleus accumbens dopamine release in adult and adolescent ratsJulie A Marusich, Mahesh Darna, A George Wilson, et al.
Head & Neck|March 20, 2023
Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti-PDL1 efficacy in head and neck cancerKourtney L Kostecki, Mari Iida, Anne L Wiley, et al.
Annals of Internal Medicine|June 16, 2004
Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working GroupJamie K Waselenko, Thomas J MacVittie, William F Blakely, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 8, 2006
Pharmacological characterization of novel water-soluble cannabinoidsBilly R Martin, Jenny L Wiley, Irina Beletskaya, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2017
Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological ConsequencesBrian F Thomas, Timothy W Lefever, Ricardo A Cortes, et al.
British Journal of Pharmacology|July 16, 2013
In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effectsB M Ignatowska-Jankowska, S Ghosh, M S Crowe, et al.
Psychopharmacology|April 1, 2010
Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodentsD Matthew Walentiny, Robert E Vann, Jonathan A Warner, et al.
Annals of the New York Academy of Sciences|September 29, 2011
Barrett's esophagus: prevalence and incidence of adenocarcinomasHelen M Shields, Gerardo Nardone, Jingjing Zhao, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 16, 2014
Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in miceJason M Wiebelhaus, Travis W Grim, Robert A Owens, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 9, 2015
A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive EffectsBogna M Ignatowska-Jankowska, Gemma L Baillie, Steven Kinsey, et al.
Pageof 53